KRAS is one of the most mutated proto-oncogene in human cancers, and is highly mutated in a variety of cancers, including pancreatic ductal adenocarcinomas (PDAC), lung cancer, and colorectal cancer (Prior et al., 2012). The gene discussed is KRAS; the disease is cancer.